Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

[1]  P. Schlag,et al.  A rapid and simple procedure for dissociation of tumor tissue from the human colon , 2004, Journal of Cancer Research and Clinical Oncology.

[2]  A. Mackensen,et al.  Induction and clonal expansion of tumor‐specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells , 2001, International journal of cancer.

[3]  R. Figlin,et al.  Dendritic cell-based immunotherapy of renal cell carcinoma , 2001, Current urology reports.

[4]  G. Ratzinger,et al.  Dendritic cells as immunologic adjuvants for the treatment of cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  V. Sharma,et al.  Dendritic Cells Armed With Anti-CD3 mAbs Reduce Pulmonary Metastases, Prolong Survival, and Engender Antitumor Effector Cells Demonstrable by Adoptive Transfer , 2000, Annals of Surgical Oncology.

[6]  D. Huhn,et al.  Increase of the Immunostimulatory Effect of Dendritic Cells by Pulsing With CA 19-9 Protein , 2000, Journal of immunotherapy.

[7]  A. Gross,et al.  Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids , 2000, Nature Medicine.

[8]  A. Schned,et al.  In vivo description of dendritic cells in human renal cell carcinoma. , 1999, The Journal of urology.

[9]  H. Klocker,et al.  Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. , 1999, The Journal of urology.

[10]  M. Roth,et al.  Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  M. Mbizvo,et al.  Dendritic Cell-Based Immunotherapy of Renal Cell Carcinoma , 1998, Urologia Internationalis.

[12]  G. Bartsch,et al.  CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer , 1998, The Lancet.

[13]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[14]  Dirk Schadendorf,et al.  Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.

[15]  C. Atkinson,et al.  Minimal recruitment and activation of dendritic cells within renal cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  S. Rafii,et al.  Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity , 1997, The Journal of experimental medicine.

[17]  R. Steinman,et al.  Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors , 1997, The Journal of experimental medicine.

[18]  S. Rosenberg,et al.  Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases , 1997, The Journal of experimental medicine.

[19]  C. Colaco,et al.  Immunotherapy: Fusion induces tumour rejection , 1997, Nature.

[20]  H. Klocker,et al.  Human renal‐cell carcinoma tissue contains dendritic cells , 1996, International journal of cancer.

[21]  E. Gilboa,et al.  Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo , 1996, The Journal of experimental medicine.

[22]  E. Lopez Hänninen,et al.  Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients. , 1996, The Journal of urology.

[23]  H. Klocker,et al.  Dendritic antigen‐presenting cells from the peripheral blood of renal‐cell‐carcinoma patients , 1995, International journal of cancer.

[24]  R. Day,et al.  Calculation of lytic units for the expression of cell-mediated cytotoxicity. , 1992, Journal of immunological methods.

[25]  T. Decker,et al.  A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. , 1988, Journal of immunological methods.

[26]  T. Logtenberg,et al.  Enumeration of IFN-γ-producing human lymphocytes by spot-ELISA: A method to detect lymphokine-producing lymphocytes at the single-cell level , 1988 .

[27]  Enumeration of IFN-gamma-producing human lymphocytes by spot-ELISA. A method to detect lymphokine-producing lymphocytes at the single-cell level. , 1988, Journal of immunological methods.

[28]  C. Korzeniewski,et al.  An enzyme-release assay for natural cytotoxicity. , 1983, Journal of immunological methods.